Sonoma Pharmaceuticals, Inc. SNOA
1.14 USD +0.04 (+3.64%)
At closeNov 3, 2026, 4:00 PM EST
1.14 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
1.08 Day range 1.16
0.85 52-week range 3.95
- YTD
- -68.68%
- 1 year
- -69.84%
Analyst view
Price target (mean) 19.50 +1610.5% upside
Now 1.14
- Target (low)
- 17.00
- Target (mean)
- 19.50
- Target (high)
- 22.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.60 | -0.60 – -0.60 | 0.00 | 0.0% | 4.06M | +29.4% | 1 |
| Next quarter | -0.60 | -0.60 – -0.60 | 0.00 | 0.0% | 4.44M | +29.1% | 1 |
| Current year | -2.80 | -2.80 – -2.80 | 0.00 | 0.0% | 15.47M | +21.5% | 1 |
| Next year | -1.20 | -1.20 – -1.20 | -2.80 | +57.1% | 19.67M | +27.2% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 5, 2023 | Ladenburg Thalmann | Initiated | — | Buy |
| Mar 6, 2018 | Maxim Group | Downgrade | Buy | Hold |
| Dec 28, 2017 | Benchmark | Initiated | — | Speculative Buy |
| Nov 10, 2017 | Maxim Group | Maintained | — | Buy |